Executive Director, Global Medical Oncology, Iza-Bren Medical Product Lead (MPL)
Core
Lead the global medical team for Izabren (BMS-986507), a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), driving clinical evidence generation, recruitment, and external advocacy across international markets for breast, lung, gastrointestinal, and genitourinary cancers.
Role type
Executive Director, Global Medical Oncology (Medical Product Lead)
Builds
Clinical evidence for Izabren ADC program
Domain
Oncology / Antibody-Drug Conjugates (ADC)
Required skills
Global medical strategy development, international team leadership, Phase 3 oncology development, ADC/bispecific antibody expertise, site engagement optimization, competitive landscape analysis, cross-functional partnership, KPI/dashboard management, scientific advocacy, change management
Preferred skills
Solid tumor experience (breast, thoracic, GI, GU), alliance partner collaboration, regulatory insight, biomarker strategy
Technologies
ADCs, bispecific antibodies, Phase 3 studies
Responsibilities
Develop and execute unified global medical strategy; lead and align global and US medical teams; optimize trial execution and site engagement; monitor competitive landscape; oversee resource allocation and budget; partner with Clinical Development, Safety, and Regulatory teams; shape external scientific leadership and engage key opinion leaders.
Seniority
Executive, strategic leadership & mentorship